Cochlear Limited (COH.AX)
AUD 256.36
(1.2%)
AUD 256.36
(1.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 579.5 Million AUD | 18.85% |
| 2023 | 487.1 Million AUD | 13.48% |
| 2022 | 475.4 Million AUD | 7.52% |
| 2021 | 451.9 Million AUD | 20.15% |
| 2020 | -181.9 Million AUD | -11.96% |
| 2019 | 409.3 Million AUD | 2.8% |
| 2018 | 383.2 Million AUD | 9.97% |
| 2017 | 347.55 Million AUD | 22.04% |
| 2016 | 296.56 Million AUD | 21.21% |
| 2015 | 236.96 Million AUD | 31.72% |
| 2014 | 154.27 Million AUD | -11.65% |
| 2013 | 202.52 Million AUD | 21.48% |
| 2012 | 94.13 Million AUD | -35.47% |
| 2011 | 243.8 Million AUD | 9.93% |
| 2010 | 244.85 Million AUD | 21.34% |
| 2009 | 207.36 Million AUD | 8.72% |
| 2008 | 190.07 Million AUD | -1.15% |
| 2007 | 169.47 Million AUD | 32.84% |
| 2006 | 131.3 Million AUD | 40.76% |
| 2005 | 91.22 Million AUD | 51.55% |
| 2004 | 57.51 Million AUD | -30.36% |
| 2003 | 80.8 Million AUD | 55.56% |
| 2002 | 56.92 Million AUD | 21.97% |
| 2001 | 50.18 Million AUD | 37.96% |
| 2000 | 33.83 Million AUD | 26.29% |
| 1999 | 26.78 Million AUD | 47.99% |
| 1998 | 18.1 Million AUD | 20.96% |
| 1997 | 14.96 Million AUD | 8.98% |
| 1996 | 13.73 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 22.93% |
| 2024 Q4 | 295 Million AUD | 0.0% |
| 2024 Q2 | 311.4 Million AUD | 0.0% |
| 2023 Q2 | 231.5 Million AUD | 0.0% |
| 2023 FY | - AUD | 13.48% |
| 2023 Q4 | 261.8 Million AUD | 0.0% |
| 2022 Q4 | 191.8 Million AUD | 0.0% |
| 2022 Q2 | 242.9 Million AUD | 0.0% |
| 2022 FY | - AUD | 7.52% |
| 2021 Q2 | 218.4 Million AUD | 0.0% |
| 2021 FY | - AUD | 20.15% |
| 2021 Q4 | 192.9 Million AUD | 0.0% |
| 2020 Q2 | 220.9 Million AUD | 0.0% |
| 2020 FY | - AUD | -11.96% |
| 2020 Q4 | 115.6 Million AUD | 0.0% |
| 2019 Q2 | 193.9 Million AUD | 0.0% |
| 2019 Q4 | 188.3 Million AUD | 0.0% |
| 2019 FY | - AUD | 2.8% |
| 2018 Q4 | 195.9 Million AUD | 0.0% |
| 2018 FY | - AUD | 9.97% |
| 2018 Q2 | 175.9 Million AUD | 0.0% |
| 2017 Q4 | 168.4 Million AUD | 0.0% |
| 2017 FY | - AUD | 22.04% |
| 2017 Q2 | 169.7 Million AUD | 0.0% |
| 2016 FY | - AUD | 21.21% |
| 2016 Q4 | 135.58 Million AUD | 0.0% |
| 2016 Q2 | 141.45 Million AUD | 0.0% |
| 2015 Q4 | 114.4 Million AUD | 0.0% |
| 2015 Q2 | 114.15 Million AUD | 0.0% |
| 2015 FY | - AUD | 31.72% |
| 2014 Q2 | 59.24 Million AUD | 0.0% |
| 2014 FY | - AUD | -11.65% |
| 2014 Q4 | 114.26 Million AUD | 0.0% |
| 2013 Q4 | 81.42 Million AUD | 67.09% |
| 2013 Q3 | 48.73 Million AUD | 0.0% |
| 2013 Q2 | 48.73 Million AUD | 107.07% |
| 2013 Q1 | 23.53 Million AUD | 0.0% |
| 2013 FY | - AUD | 21.48% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 Q2 | 23.53 Million AUD | -61.39% |
| 2012 Q1 | 60.95 Million AUD | 0.0% |
| 2012 FY | - AUD | -35.47% |
| 2012 Q3 | 23.53 Million AUD | 0.0% |
| 2011 Q1 | 55.44 Million AUD | 0.0% |
| 2011 Q2 | 60.95 Million AUD | 9.93% |
| 2011 Q3 | 60.95 Million AUD | 0.0% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 FY | - AUD | 9.93% |
| 2010 FY | - AUD | 21.34% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 55.44 Million AUD | 0.0% |
| 2010 Q2 | 55.44 Million AUD | 19.68% |
| 2010 Q1 | 46.32 Million AUD | 0.0% |
| 2009 Q2 | 46.32 Million AUD | 8.76% |
| 2009 FY | - AUD | 8.72% |
| 2009 Q3 | 46.32 Million AUD | 0.0% |
| 2009 Q1 | 42.59 Million AUD | 0.0% |
| 2009 Q4 | - AUD | -100.0% |
| 2008 Q1 | 43.83 Million AUD | 0.0% |
| 2008 Q2 | 42.59 Million AUD | -2.83% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 FY | - AUD | -1.15% |
| 2008 Q3 | 42.59 Million AUD | 0.0% |
| 2007 FY | - AUD | 32.84% |
| 2007 Q3 | 43.83 Million AUD | 0.0% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 Q2 | 43.83 Million AUD | 46.81% |
| 2007 Q1 | 29.85 Million AUD | 0.0% |
| 2006 FY | - AUD | 40.76% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q3 | 29.85 Million AUD | 0.0% |
| 2006 Q2 | 29.85 Million AUD | 29.27% |
| 2006 Q1 | 23.09 Million AUD | 0.0% |
| 2005 Q1 | 14.53 Million AUD | 0.0% |
| 2005 Q2 | 23.09 Million AUD | 58.91% |
| 2005 Q3 | 23.09 Million AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 FY | - AUD | 51.55% |
| 2004 Q1 | 34.75 Million AUD | 0.0% |
| 2004 FY | - AUD | -30.36% |
| 2004 Q2 | 14.53 Million AUD | -58.18% |
| 2004 Q3 | 14.53 Million AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2003 FY | - AUD | 55.56% |
| 2003 Q2 | 34.75 Million AUD | 43.26% |
| 2003 Q1 | 24.25 Million AUD | 0.0% |
| 2003 Q3 | 34.75 Million AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2002 FY | - AUD | 21.97% |
| 2002 Q2 | 24.25 Million AUD | 19.26% |
| 2002 Q3 | 24.25 Million AUD | 0.0% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 Q1 | 20.34 Million AUD | 0.0% |
| 2001 Q1 | 12.98 Million AUD | 0.0% |
| 2001 Q3 | 20.34 Million AUD | 0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2001 FY | - AUD | 37.96% |
| 2001 Q2 | 20.34 Million AUD | 56.69% |
| 2000 Q4 | - AUD | -100.0% |
| 2000 FY | - AUD | 26.29% |
| 2000 Q2 | 12.98 Million AUD | 28.57% |
| 2000 Q1 | 10.09 Million AUD | 0.0% |
| 2000 Q3 | 12.98 Million AUD | 0.0% |
| 1999 Q3 | 10.09 Million AUD | 0.0% |
| 1999 Q2 | 10.09 Million AUD | 28.68% |
| 1999 Q1 | 7.84 Million AUD | 0.0% |
| 1999 FY | - AUD | 47.99% |
| 1999 Q4 | - AUD | -100.0% |
| 1998 Q4 | - AUD | -100.0% |
| 1998 FY | - AUD | 20.96% |
| 1998 Q1 | 6.84 Million AUD | 0.0% |
| 1998 Q3 | 7.84 Million AUD | 0.0% |
| 1998 Q2 | 7.84 Million AUD | 14.67% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 Q1 | 6.53 Million AUD | 0.0% |
| 1997 Q2 | 6.84 Million AUD | 4.69% |
| 1997 Q3 | 6.84 Million AUD | 0.0% |
| 1997 FY | - AUD | 8.98% |
| 1996 Q3 | 6.53 Million AUD | 0.0% |
| 1996 Q2 | 6.53 Million AUD | 0.0% |
| 1996 Q4 | 6.53 Million AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 1706.743% |
| Adherium Limited | -11.56 Million AUD | 5111.04% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 7973.556% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 10784.996% |
| Anteris Technologies Ltd | -66.9 Million AUD | 966.163% |
| Control Bionics Limited | -5.15 Million AUD | 11334.526% |
| CardieX Limited | -6.71 Million AUD | 8733.986% |
| Compumedics Limited | 2.78 Million AUD | -20678.057% |
| CleanSpace Holdings Limited | -3.49 Million AUD | 16696.006% |
| Cyclopharm Limited | -3.03 Million AUD | 19194.534% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | 27811.256% |
| Nova Eye Medical Limited | -5.97 Million AUD | 9792.256% |
| HeraMED Limited | -3.97 Million AUD | 14689.4% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 2749.699% |
| ImpediMed Limited | -22.05 Million AUD | 2727.999% |
| InhaleRx Limited | -1.41 Million AUD | 41090.477% |
| LBT Innovations Limited | -4.04 Million AUD | 14412.176% |
| Micro-X Limited | -14.35 Million AUD | 4138.046% |
| Neurotech International Limited | -8.24 Million AUD | 7129.327% |
| OncoSil Medical Limited | -11.97 Million AUD | 4938.775% |
| PolyNovo Limited | 5.17 Million AUD | -11108.897% |
| Respiri Limited | -7.04 Million AUD | 8319.964% |
| SomnoMed Limited | -2.32 Million AUD | 24986.059% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 6474.832% |
| Uscom Limited | -1.5 Million AUD | 38495.028% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | 11884.697% |